PubMed:12374875 / 88-501
Annnotations
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 12374875-3#40#45#gene820 | 289-294 | gene820 | denotes | LL-37 |
| 12374875-3#116#133#diseaseC0011615 | 365-382 | diseaseC0011615 | denotes | atopic dermatitis |
| 12374875-3#116#133#diseaseC0013595 | 365-382 | diseaseC0013595 | denotes | atopic dermatitis |
| 40#45#gene820116#133#diseaseC0011615 | 12374875-3#40#45#gene820 | 12374875-3#116#133#diseaseC0011615 | associated_with | LL-37,atopic dermatitis |
| 40#45#gene820116#133#diseaseC0013595 | 12374875-3#40#45#gene820 | 12374875-3#116#133#diseaseC0013595 | associated_with | LL-37,atopic dermatitis |
PubMed_Structured_Abstracts
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-413 | BACKGROUND | denotes | The innate immune system of human skin contains antimicrobial peptides known as cathelicidins (LL-37) and beta-defensins. In normal skin these peptides are negligible, but they accumulate in skin affected by inflammatory diseases such as psoriasis. We compared the levels of expression of LL-37 and human beta-defensin 2 (HBD-2) in inflamed skin from patients with atopic dermatitis and from those with psoriasis. |